Use of disease risk scores in pharmacoepidemiologic studies

被引:106
作者
Arbogast, Patrick G. [1 ]
Ray, Wayne A. [2 ,3 ]
机构
[1] Vanderbilt Univ, Dept Biostat, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Prevent Med, Nashville, TN 37232 USA
[3] Nashville Vet Adm, Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN 37232 USA
基金
美国医疗保健研究与质量局;
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROPENSITY SCORE; STRATIFICATION; DEATH;
D O I
10.1177/0962280208092347
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Automated databases are increasingly used in pharmacoepidemiologic studies. These databases include records of prescribed medications and encounters with medical care providers from which one can construct very detailed Surrogate measures for both drug exposure and covariates that are potential confounders. Often it is possible to track day-by-day changes in these variables. However, while this information is often critical for study success, its Volume can pose challenges for statistical analysis. One common approach is the use of propensity scores. An alternative approach is to construct a disease risk score. This is analogous to the propensity score in that it calculates a summary measure from the covariates. However, the disease risk score estimates the probability or rate of disease Occurrence conditional oil being unexposed. The association between exposure and disease is then estimated adjusting for the disease risk score in place of the individual covariates. This review describes the use of disease risk scores in phamacoepidemiologic studies, and includes a brief discussion of their history, a more detailed description of their construction and use, a summary of simulation Studies comparing their performance vis-a-vis traditional models, a comparison of their utility with that of propensity scores, and some further topics for future research.
引用
收藏
页码:67 / 80
页数:14
相关论文
共 25 条
  • [1] BOOTSTRAP INVESTIGATION OF THE STABILITY OF A COX REGRESSION-MODEL
    ALTMAN, DG
    ANDERSEN, PK
    [J]. STATISTICS IN MEDICINE, 1989, 8 (07) : 771 - 783
  • [2] Adjustment for multiple cardiovascular risk factors using a summary risk score
    Arbogast, Patrick G.
    Kaltenbach, Lisa
    Ding, Hua
    Ray, Wayne A.
    [J]. EPIDEMIOLOGY, 2008, 19 (01) : 30 - 37
  • [3] COOK EF, 1989, J CLIN EPIDEMIOL, V42, P317
  • [4] ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES
    DEYO, RA
    CHERKIN, DC
    CIOL, MA
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) : 613 - 619
  • [5] Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study
    Graham, DJ
    Campen, D
    Hui, R
    Spence, M
    Cheetham, C
    Levy, G
    Shoor, S
    Graham, D
    [J]. LANCET, 2005, 365 (9458) : 475 - 481
  • [6] The role of the propensity score in estimating dose-response functions
    Imbens, GW
    [J]. BIOMETRIKA, 2000, 87 (03) : 706 - 710
  • [7] Joffe MM, 1999, AM J EPIDEMIOL, V150, P327
  • [8] Methods to assess intended effects of drug treatment in observational studies are reviewed
    Klungel, OH
    Martens, EP
    Psaty, BM
    Grobbee, DE
    Sullivan, SD
    Stricker, BHC
    Leufkens, HGM
    de Boer, A
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (12) : 1223 - 1231
  • [9] Korn E.L., 1999, WILEY S PRO STAT SUR, P278
  • [10] On the estimation and use of propensity scores in case-control and case-cohort studies
    Mansson, Roger
    Joffe, Marshall M.
    Sun, Wenguang
    Hennessy, Sean
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 166 (03) : 332 - 339